TGFB1 and carcinoma: TGF-β is a powerful inducer of epithelial-mesenchymal transition (EMT), a differentiation switch that is required for transitory invasiveness of carcinoma cells, the generation of cancer stem cells (CSCs), and phenotypic plasticity, eventually resulting in tumor heterogeneity and resistance to standard chemotherapies [5,6].